<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03626220</url>
  </required_header>
  <id_info>
    <org_study_id>CMUH106-REC2-117</org_study_id>
    <nct_id>NCT03626220</nct_id>
  </id_info>
  <brief_title>Evaluation of the Efficacy of Acupuncture in Chemotherapy Induced Peripheral Neuropathy</brief_title>
  <official_title>Evaluation the Efficacy of Acupuncture in Chemotherapy Induced Peripheral Neuropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peripheral neuropathy is currently the second most common side effect after chemotherapy,
      second only to the side effects of blood toxicity. A variety of chemotherapy drugs may induce
      peripheral neurotoxicity, and cause by the cumulative dose of chemotherapy drugs. Symptoms
      include sensory parasthesia, feeling dull or numbness, glove-like feeling distributed in the
      palm. The currently most effective way is to interrupt the treatment or adjust the dose of
      chemotherapeutic drugs, but it is easy to make patients discontinue chemotherapy. The purpose
      of this study is to explore the impact of acupuncture on neurological symptoms and quality of
      life. Three kinds of questionnairs will be used:(1) Brief pain inventory- short form to
      assess the extent of pain, and the impact of daily life. (2) FACT/GOG-NTX-13 (Version 4) to
      assess changes in neurological symptoms; (3) WHOQOL-BREF to assess changes in the quality of
      life of patients. The course of treatment was evaluated for nine weeks. Changes in
      neurological function and quality of life will be evaluated before treatment, the third week
      of treatment, the sixth week of treatment, till the ninth week. The aim of this study is to
      confirm that acupuncture can improve peripheral neuropathy after chemotherapy, in order to
      enhance breast cancer patients' quality of life, and provide the new opportunity for
      integrative therapy between Chinese and Western medicine.

      Keywords：acupuncture , chemotherapy-induced peripheral neuropathy
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 27, 2018</start_date>
  <completion_date type="Anticipated">October 10, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 10, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>FACT/GOG-NTX-13 (Version 4)</measure>
    <time_frame>4 times in 9 weeks</time_frame>
    <description>Prorated subscale score = [Sum of item scores] x [N of items in subscale]÷ [N of items answered] For all FACIT scales and symptom indices, the higher the score the better the QOL.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Randomized Controlled Trial</condition>
  <condition>Breast Cancer</condition>
  <condition>Chemotherapy-induced Peripheral Neuropathy</condition>
  <arm_group>
    <arm_group_label>acupuncture group</arm_group_label>
    <description>acupuncture with de-chi sensation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham acupuncture group</arm_group_label>
    <description>skin-deep acupuncture without de-chi sensation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>acupuncture</intervention_name>
    <description>manually manipulate acupuncture at CV6 and three acupoints on each arms and legs</description>
    <arm_group_label>acupuncture group</arm_group_label>
    <arm_group_label>sham acupuncture group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        breast cancer patients who complete whole courses of chemotherapy obtain peripheral
        neuropathy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  more than 20 yeas old Female

          -  TypeI-IV breast cancer patients

          -  complete chemotherapy

          -  chemotherapeutic agents include taxanes、platinum compounds ect

          -  ECOG&lt;3

          -  NCI common terminology criteria for adverse events,v4.0: more than grade1 。

        Exclusion Criteria:

          -  average life expectancy&lt;3months

          -  diabetic neuropathy

          -  inflammatory neuropathy

          -  metabolic neuropathy

          -  severe blood coagulopathy or bleeding tendency

          -  unstable heart disease

          -  neuro-muscular disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chien-Chen Huang(Attending physician), master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Traditional Chinese medcine department, An-Nan Municiple Hospital, China Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chien-Chen Huang(Attending physician), master</last_name>
    <phone>(06)355-3111</phone>
    <phone_ext>2231</phone_ext>
    <email>chenchinh2013@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>An Nan Hospital,China Medical University</name>
      <address>
        <city>Tainan</city>
        <zip>709</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tsai-Wang Chang(Professor), Doctor</last_name>
      <phone>+886-6-3553111</phone>
      <email>D71568@mail.tmanh.org.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/27013473</url>
    <description>pubmed</description>
  </link>
  <results_reference>
    <citation>Greenlee H, Crew KD, Capodice J, Awad D, Buono D, Shi Z, Jeffres A, Wyse S, Whitman W, Trivedi MS, Kalinsky K, Hershman DL. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer. Breast Cancer Res Treat. 2016 Apr;156(3):453-464. doi: 10.1007/s10549-016-3759-2. Epub 2016 Mar 25.</citation>
    <PMID>27013473</PMID>
  </results_reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 8, 2018</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2018</study_first_posted>
  <last_update_submitted>August 31, 2019</last_update_submitted>
  <last_update_submitted_qc>August 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University Hospital</investigator_affiliation>
    <investigator_full_name>Chien-Chen Huang</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>chemotherapy-induced peripheral neuropathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>https://www.ncbi.nlm.nih.gov/pubmed/27013473</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

